Summertime Means Renewal Time! 2017 Pricing and Special Offers Are Now Available

Your 2017 renewal invoice will be arriving soon. In addition to renewing your subscriptions early and securing uninterrupted access for your users, you also have an opportunity to enhance your collection with new or complementary journals at a discounted rate. Your account representative is ready to help you renew, learn about additional titles relevant to your collection, and to advise you of special offers and discounts.

Contact us today to lock in your renewal.

Mary Ann Liebert, Inc. Journal Portfolio Sees Significant Impact
Factor Growth

Mid-June is always an exciting time in the halls of Mary Ann Liebert, Inc., as that is when the Impact Factors are announced. Once again, this year’s announcement was cause for celebration — more than 60% of our portfolio of previously indexed journals received increased impact factors, with 17 titles seeing double-digit percentage increases! Of particular note are the increases and continued impact of Journal of Neurotrauma with an 18% increase, Journal of Endourology with a 23% increase, DNA and Cell Biology with a 25% increase, and Environmental Engineering Science with a 49% increase.

Seven journals received first impact factors this year, including Soft Robotics with an astounding first impact factor of 6.130, and LGBT Health with a first impact factor of 2.261.

Flagship publications Human Gene Therapy, Tissue Engineering, and Stem Cells and Development maintained strong impact factors and reinforced their positions as leaders in their respective fields.

Are these high-impact titles in your collection? If not, be sure to add them today.

Big Data Now Indexed in MEDLINE/PubMed

We are delighted that Big Data is now indexed in MEDLINE/PubMed. This is another “feather in the cap” for this rapidly growing journal, which in March was also accepted for inclusion in Thomson Reuters Web of Science™ Science Citation Index Expanded (SciSearch) and Journal Citation Reports/Science Edition. In June, it also received its first Impact Factor of 1.696, further testament to the Journal’s position as the premier source for world-class research exploring the challenges and opportunities in collecting, analyzing, and disseminating vast amounts of data. Contact us for more information about Big Data.

Health Equity, New Peer-Reviewed Open Access Journal Launching
Fall 2016

We are pleased to announce the launch of Health Equity, a new peer-reviewed open access journal that will address the urgent need for authoritative information about health disparities and health equity among vulnerable populations. Content will range from translational research to prevention, diagnosis, treatment, and management of disease and illness toward the goal of optimal outcomes and ultimately health equity for all.  Health Equity is being launched with a grant from the W.K. Kellogg Foundation to ensure that it is accessible as widely as possible and to provide a framework for achieving health equity for children, families, and communities by reducing and ultimately eliminating disparities in health and its social, economic, and environmental determinants. Click here to sign up for free Health Equity email alerts.

New Editorial Leadership

We are pleased to welcome the following new journal Editors:

Nucleic Acid Therapeutics—Prof. Annemieke Aartsma-Rus, Leiden University Medical Center, Netherlands
Prof. Annemieke Aartsma-Rus, Nucleic Acid Therapeutics new Co-Editor-in-Chief, holds a chair in translational genetics at the Leiden University Medical Center (the Netherlands) and is one of the pioneers of the exon skipping approach for Duchenne muscular dystrophy. In 2011 she received the Duchenne Award from the Dutch Duchenne Parent Project in recognition of this work and her dedication to the Duchenne field. She is a member of the board of directors of the Oligonucleotide Therapeutics Society.

High Altitude Medicine & Biology—Benjamin Honigman, MD, University of Colorado School of Medicine
Dr. Benjamin Honigman, Professor and Founding Chair of Emergency Medicine and Associate Dean for Clinical Outreach at University of Colorado School of Medicine, has been appointed Deputy Editor of High Altitude Medicine & Biology. Dr. Honigman graduated from Tufts Medical School and completed his residency in emergency medicine at Denver General Hospital in 1979. Prior to joining the University of Colorado School of Medicine, he was the Editor-in-Chief at Micromedex developing the EMERGINDEX system.

The Journal of Alternative and Complementary Medicine—John Weeks
John Weeks has been appointed Editor-in-Chief of The Journal of Alternative and Complementary Medicine. Mr. Weeks is a writer, speaker, organizer, consultant, and executive with three decades of experience in the movement for integrative health and medicine including most recently as the co-founder and for 8 years the director of the Academic Collaborative for Integrative Health. His work is at the convergence of that historic trend and the medical industry’s engagement of a values-based focus on creating health.